# Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL

> **NCT04059796** · NA · COMPLETED · sponsor: **Omega Ophthalmics** · enrollment: 6 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** Omega Gemini III Rev 2 Device
- **DEVICE:** Control Eye

## Key facts

- **NCT ID:** NCT04059796
- **Lead sponsor:** Omega Ophthalmics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-21
- **Primary completion:** 2020-08-28
- **Final completion:** 2020-08-28
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04059796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04059796, "Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04059796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*